Russia Viscosupplementation Market

Viscosupplementation Market: Three Injection Viscosupplementation Likely to be the Most Preferred Treatment Option for Osteoarthritis: Russia Industry Analysis & Opportunity Assessment, 2016-2026

Ask The Analyst Customization Available Request Methodology

Single injection viscosupplementation segment is anticipated to record the highest CAGR during the projected period

The single injection viscosupplementation segment in the Russia viscosupplementation market is expected to expand at the fastest and highest CAGR of 6.0% over the forecast period, due to relatively less competition across the product type segments. The three injection viscosupplementation product type segment was estimated to account for more than 69.4% share of the Russia viscosupplementation market in 2016, which is projected to increase to over 68.8% by the end of 2026. In Russia, three injection viscosupplementation is likely to be the highly preferred treatment of choice for osteoarthritis over the projected period and this is the precise reason that by the end of 2026, the three injection viscosupplementation product type segment is estimated to reach a market valuation in excess of US$ 23.5Mn. The three injection viscosupplementation product type segment is projected to be the most attractive segment in the Russia viscosupplementation market.

Rising obesity and ageing population expected to drive the growth of the three injection viscosupplementation segment in Russia

Viscosupplemets are hyaluronic acid doses that are injected in the knee joints for the treatment of osteoarthritis (OA). The rising obesity rate, coupled with a rapidly increasing geriatric population in Russia is giving rise to an increasing number of cases of knee osteoarthritis. This factor is driving the growth of the single injection viscosupplementation segment in the Russia viscosupplementation market. Increasing ageing population is another factor that is creating robust development in the Russia viscosupplementation market. Prevalence of osteoarthritis in the adult population in Russia is approximately 13%. Knee osteoarthritis is causing disability in the ageing population in Russia and this is the precise reason for the rise in demand for three injection viscosupplementation. Three injection viscosupplementation is a cost-effective procedure that reduces the cost burden of knee osteoarthritis patients. Several drugs for three injection viscosupplementation are in the pipeline and this is further creating a positive impact on this segment. Better patient compliance and reduction in the number of hospital visits is expected to drive the market growth of the three injection viscosupplementation segment over the forecast period.

Non-consideration of reimbursement by insurance companies in Russia is likely to be a hindrance to the growth in demand for three injection viscosupplementation  

The cost of single injection viscosupplementation is lesser than three injection viscosupplementation. Besides, these three injections are available through online portals or can be procured directly from the pharmacists as well. However, several insurance companies and authorities do not consider these in the reimbursement list of products. Physicians have noted that the formulation of updated treatment guidelines by Osteoarthritis Research Society International (OARSI) for knee osteoarthritis has been restricting the overall outlook on viscosupplementation prescription. This is expected to lead to increased insurance denials for three injection viscosupplementation. Three injection viscosupplementation is a lengthy procedure wherein patients suffering from osteoarthritis need to take three injections within the span of a certain time period. Owing to these restraints, single injections are expected to gain more popularity in Russia in the years to come.

russia viscosupplementation market

Market share of companies operating in the Russia viscosupplementation market

The Russia viscosupplementation market is highly fragmented. Key players such as Hyaltech, Croma-Pharma GmbH and TRB Chemedica contribute around 65% of the market share. Hyaltech alone grabs more than 40% market share.

An expansion of production capacity by establishing new subsidiaries is anticipated to contribute immensely towards growing revenues of viscosupplementation products in Russia – this is the essence of Future Market Insights’ new publication titled “ Viscosupplementation Market: Russia Industry Analysis & Opportunity Assessment, 2016-2026.” This 10-year comprehensive report focusses on Russia’s viscosupplementation market that is significantly transforming its enterprises and businesses. While researching this market, our expert analysts have found that Russia is likely to hold a majority of the market share in the Eastern Europe viscosupplementation market owing to the rapid increase in knee osteoarthritis patients. We have given extensive focus on increasing domestic supply of viscosupplementation products that are creating massive growth opportunities for several manufacturers, thus driving revenues and meeting patients’ expectations. 

The report highlights that strengthening of the product pipeline with new combination products along with a focus on the supply chain are the key focus areas for existing players in the Russia viscosupplementation market. While identifying the differentiating strategies of this market, we have come to the conclusion that manufacturers are more focussed on developing simple and convenient single use viscosupplementation products such as single injections and mini-injections, thus resulting in increased product offerings.

Clinical trials are the key research tools deployed in the Russia viscosupplementation market report

What makes this report exclusive than any other report is our special coverage of regulatory guidelines in the Russia viscosupplementation market. Our analysts have focussed on clinical trials that are key research tools for enhancing medical knowledge and patient care. We have considered the pricing and reimbursement scenario and have come to the conclusion that product pricing is determined by negotiations between hospitals and the concerned medical device companies. This inclusive report includes a market overview with a comprehensive market forecast and information on key drivers, restraints, trends and opportunities. Impact analyses of key growth drivers and restraints based on the weighted average model have been included in the Russia viscosupplementation market report after an in-depth analysis to better equip readers with meaningful insights on ongoing developments in the Russia viscosupplementation market.

A competitive landscape of the Russia viscosupplementation market has been provided in the last section of the report to showcase a dashboard view based on categories of providers in the value chain, their product portfolio and key differentiators. Key categories of providers covered in the report are manufacturers of hyaluronic acid injections. This section is primarily designed to provide clients with an objective and detailed comparative assessment of key providers specific to a market segment in the Russia viscosupplementation value chain and potential players for the same. Report audiences can gain segment-specific vendor insights to identify and evaluate key competitors based on an in-depth assessment of capabilities and successes in the Russia viscosupplementation market. Detailed profiles of some of the providers are also included within the scope of the report to evaluate their long-term and short-term strategies, key offerings, SWOT analysis and recent developments in the Russia viscosupplementation market.

The market is divided into two segments based on product type and end use:

By Product Type

By End Use

  • Single Injection Viscosupplementation

  • Three Injection Viscosupplementation

  • Five Injection Viscosupplementation

  • Hospitals

    • 500+ Bedded

    • 250-500 Bedded

    • Less Than 250 Bedded

  •  Ambulatory Surgical Centres

  • Orthopaedic Clinics

Our unique research methodology identifies potential resources from a sales and delivery perspective in the Russia viscosupplementation market

The report highlights the performance of the viscosupplementation market in Russia and provides a detailed outlook for every market segment for 2016–2026 in terms of market size, Y-o-Y growth rates, absolute $ opportunity and BPS analysis. We have considered 2015 as the base year and provided data for the next 10 years. In addition, it is imperative to note that given the ever-fluctuating nature of the Russian economy, we have not only conducted the market forecast in terms of CAGR but have also provided an analysis of the Russia viscosupplementation market based on key parameters such as year-on-year (Y-o-Y) growth rates to understand the predictability of the market and to identify the right opportunities across the Russia viscosupplementation market. Further, market segments in terms of product type and end user have been analysed in terms of Basis Point Share (BPS) to understand the segmental contribution to market growth. This detailed level of information is important for identifying various key trends emerging in the Russia viscosupplementation market. Another useful feature of this report is the analysis of key segments in terms of absolute dollar opportunity, critical in assessing the level of opportunity that market players can look to achieve, as well as to identify potential resources from a sales and delivery perspective in the Russia viscosupplementation market.

Russia Viscosupplementation Market Reports - Table of Contents

1.  Executive Summary

2.  Market Introduction

2.1. Market Definition

2.2. Market Taxonomy

3.  Global Russia Viscosupplementation Market Analysis Scenario

3.1. Pricing Analysis and Projection

3.2. Market Size (US$ Mn) and Forecast , 2015-2026

3.2.1. Market Size and Y-o-Y Growth

3.2.2. Absolute $ Opportunity

3.3. Market Overview

3.3.1. Value Chain

4.  Market Dynamics

4.1. Macro-economic Factors

4.2. Drivers

4.2.1. Supply Side

4.2.2. Demand Side

4.3. Restraints

4.4. Opportunity

4.5. Forecast Factors – Relevance and Impact

4.6. Key Regulations

4.7. Pipeline Product Assessment

4.8. Pricing and Reimbursement Scenario

5. Russia Viscosupplementation Market Value and Volume Analysis  and Forecasts, By Product Type 

5.1. Introduction

5.2. Basis Point Share (BPS) Analysis By Product Type 

5.3. Y-o-Y Growth Projections By Product Type 

5.4. Market Value Forecast By Product Type , 2016–2026

5.4.1. Single Injection Viscosupplementation

5.4.2. Three Injection Viscosupplementation

5.4.3. Five Injection Viscosupplementation

5.5. Prominent Trends

5.6. Market Attractiveness By Product Type 

6.  Russia Viscosupplementation Market Value and Volume Analysis and Forecasts, By End User 

6.1. Introduction

6.2. Basis Point Share (BPS) Analysis By End User 

6.3. Y-o-Y Growth Projections By End User 

6.4. Market Value Forecast By End User , 2016–2026

6.4.1. Hospitals 

6.4.1.1. 500+ Beds

6.4.1.2. 250-499 Beds

6.4.1.3. Less than 250 Beds

6.4.2. Ambulatory Surgical Centers

6.4.3. Orthopedic Clinics

6.5. Prominent Trends

6.6. Market Attractiveness By End User 

7. Competition Landscape

7.1.Competition Dashboard

7.2. Company Share Analysis (2015)

7.3.Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)

7.3.1. Anika Therapeutics Inc.

7.3.2. Bioventus LLC

7.3.3. Ferring B.V

7.3.4. Fidia Pharmaceutici S.p.A

7.3.5. MEDA Pharmaceuticals Switzerland GmbH

7.3.6. Sanofi S.A

7.3.7. ZIMMER BIOMET HOLDINGS, INC

8. Assumptions and Acronyms Used

9. Research Methodology

Russia Viscosupplementation Market Reports - List of Tables

Table 1: Russia Viscosupplementation Market Value (US$ Mn), by Product Type, 2015–2026

Table 2: Russia Viscosupplementation Market Volume (Units), by Product Type, 2015–2026

Table 3: Russia Viscosupplementation Market Value (US$ Mn), by End-use, 2015–2026

Table 4: Russia Viscosupplementation Market Volume (Units), by End-use, 2015–2026

Russia Viscosupplementation Market Reports - List of Figures

Figure 1: Russia Viscosupplementation Market Value Forecast (US$ Mn), 2016–2026

Figure 2: Russia Viscosupplementation Market Absolute $ Opportunity, 2016–2026

Figure 3: Russia Viscosupplementation Market Value Share, by Product Type, 2016 & 2026

Figure 4: Russia viscosupplementation  Y-o-Y Growth, by Product Type, 2016–2026

Figure 5: Russia Viscosupplementation Market Value Forecast (US$ Mn), by Single Injection Viscosupplementation Product Type, 2015–2026

Figure 6: Russia Viscosupplementation Market Absolute $ Opportunity, by Single Injection Viscosupplementation Product Type, 2015–2026

Figure 7: Russia Viscosupplementation Market Value Forecast (US$ Mn), by Three Injection Viscosupplementation Product Type, 2015–2026

Figure 8: Russia Viscosupplementation Market Absolute $ Opportunity, by Three Injection Viscosuplementation Product Type, 2015–2026

Figure 9: Russia Viscosupplementation Market Value Forecast (US$ Mn), by Five Injection viscosupplementation Product Type, 2015–2026

Figure 10: Russia Viscosupplementation Market Absolute $ Opportunity, by Five Injection viscosupplementation Product Type, 2015–2026

Figure 11: Russia Viscosupplementation Market Attractiveness Analysis, by Product Type, 2015–2026

Figure 12: Russia Viscosupplementation Market Value Share, by End-use, 2016 & 2026

Figure 13: Russia Viscosupplementation Market Y-o-Y Growth Rate, by End-use, 2015–2026

Figure 14: Russia Viscosupplementation Market Value Forecast (US$ Mn), by Hospitals End-use Segment, 2015–2026

Figure 15: Russia Viscosupplementation Market Absolute $ Opportunity, by Hospitals End-use Segment, 2015–2026

Figure 16: Russia Viscosupplementation Market Value Forecast (US$ Mn), by Ambulatory Surgical Centres End-use Segment, 2015–2026

Figure 17: Russia Viscosupplementation Market Absolute $ Opportunity, by Ambulatory Surgical Centres End-use Segment, 2015–2026

Figure 18: Russia Viscosupplementation Market Value Forecast (US$ Mn), by Orthopediac Clinics End-use Segment 2015–2026

Figure 19: Russia Viscosupplementation Market Absolute $ Opportunity, by Orthopediac Clinics End-use Segment, 2015–2026

Figure 20: Russia Viscosupplementation Market Attractiveness Analysis, by End-Use, 2015–2026